Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)

BACKGROUND: Major depressive disorder (MDD) is a common, chronic, debilitating mood disorder that causes serious functional impairment and significantly decreased quality of life. Pharmacotherapy represents the first-line treatment option; however, only approximately one third of patients respond to...

Descripción completa

Detalles Bibliográficos
Autores principales: Minelli, Alessandra, Barlati, Stefano, Vitali, Erika, Bignotti, Stefano, Dattilo, Vincenzo, Tura, Giovanni Battista, Maffioletti, Elisabetta, Giacopuzzi, Edoardo, Santoro, Vincenza, Perusi, Giulia, Cobelli, Chiara, Magri, Chiara, Bonizzato, Silvia, Bocchio-Chiavetto, Luisella, Spina, Edoardo, Vita, Antonio, Gennarelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665317/
https://www.ncbi.nlm.nih.gov/pubmed/34895291
http://dx.doi.org/10.1186/s13063-021-05775-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665317/
https://www.ncbi.nlm.nih.gov/pubmed/34895291
http://dx.doi.org/10.1186/s13063-021-05775-8

Ejemplares similares